← Open Payments lookup

MARITZA PELLEGRINI: Open Payments

NPI 1972285104 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$753 in 60 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $753

Food & beverage: $753
CompanyPaymentsAmount
ABBVIE INC.41$397
Alkermes, Inc.4$72
Otsuka America Pharmaceutical, Inc.3$54
Teva Pharmaceuticals USA, Inc.3$53
Lilly USA, LLC2$44
Neurocrine BioSciences, Inc.2$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Takeda Pharmaceuticals U.S.A., Inc.1$21
Neos Therapeutics, LP1$18
Vanda Pharmaceuticals Inc.1$17

Products named: VRAYLAR, ARISTADA, REXULTI, AMYVID, INGREZZA, AUSTEDO XR, CAPLYTA, TRINTELLIX.

Industry payments across NJ — which companies pay providers there.